Selected references – MACSQuant® Tyto® Family of cell sorters

Backed by more than 200 peer‑reviewed publications, the MACSQuant Tyto Family has established itself as a powerful solution across basic research, translational studies, and emerging therapeutic applications.

Logo

Selected references – MACSQuant® Tyto® Family of cell sorters

The MACSQuant Tyto Family delivers gentle, high-performance microfluidic sorting in a closed cartridge. With a versatile cartridge portfolio, hands-off operation, and support for up to 4 lasers and 12 fluorescent channels, our cell sorters expand your applications with exceptional ease and safety.

Decorative publications icon

200+ peer-reviewed publications

Decorative stethoscope and Erlenmeyer flask icon

16 clinical trials
33 in preclinical phase

Decorative worldwide icon

Trusted worldwide across diverse applications

Expand your cell sorting possibilities: Explore what´s possible!

Immune cells

Regulatory T cells

  • Maintenance DNA methylation is required for induced Treg reparative function following viral pneumonia in mice.
    Joudi, A. M. et al. (2025) J. Clin. Invest. 135: e192925. | Read article

  • Novel enzyme-based reduced representation method for DNA methylation profiling with low inputs.
    Liu, Q. et al. (2025) Nucleic Acids Res. 53: gkaf558. | Read article

  • AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia.
    Torres Acosta, M. A. et al. (2025) J. Clin. Invest. 135: e179572. | Read article

  • Acidity induces durable enhancement of Treg cell suppressive functions for tumor immune evasion.
    Mani, N. L. et al. (2024) Mol. Immunol. 174: 57–68. | Read article

Helper and cytotoxic T cells

  • Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.
    Fisher, K. et al. (2026) Nat. Immunol. 27: 812–826. | Read article

  • Exacerbation of Dahl SS hypertension and renal damage by NOX2 in CD4+ T Cells.
    Walton, S. D. et al. (2025) Hypertension 82: 2098–2111. | Read article

  • UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.
    Laheurte, C. et al. (2025) Cell Rep. Med. 6: 102196. | Read article

  • Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells.
    Cornish, D. et al. (2025) PLoS Pathog. 21: e1013745. | Read article

  • T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses.
    Sala, E. et al. (2025) EMBO J. 44: 2400–2423. | Read article

  • Glycolysis maintains effector function of lung Th17 TRM cells in precision cut lung slices.
    Yang, H. et al. (2025) iScience 28: 114051. | Read article

  • Case report: A multi-peptide vaccine targeting individual somatic mutations induces tumor infiltration of neoantigen-specific T cells in a patient with metastatic colorectal cancer.
    Rabsteyn, A. et al. (2025) Vaccines (Basel) 13: 960. | Read article

  • Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis.
    Scholten, D. et al. (2025) J. Clin. Invest. 135: e193521. | Read article

  • In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination.
    Zelba, H. et al. (2025) J. Immunother. Cancer 13: e011070. | Read article

  • Distinct transcriptomic signatures in pulmonary tissue resident and vascular resident-like T cells in nonhuman primates.
    Melton, A. et al. (2025) iScience 28: 112745. | Read article

γδ T cells

  • TCRγ constant usage tunes human γδ T cell antigen sensitivity, thymic programming, and peripheral function.
    Viswanathan, M. et al. (2026) Sci. Immunol. 11: 7167. | Read article

  • γδ T cells target and ablate senescent cells in aging and alleviate pulmonary fibrosis.
    Meca-Laguna, G. et al. (2025) bioRxiv. doi: https://doi.org/10.1101/2025.05.05.652251. | Read article

B cells

  • CLL cell-derived soluble factors do not influence the functionality of normal B cells.
    Elbert, M. M. et al. (2026) Front. Immunol. 17: 1794418. | Read article

  • Assessing the impact of cell isolation method on B cell gene expression using next-generation sequencing.
    Henning, A. N. et al. (2025) Exp Hematol. 146: 104766. | Read article

  • Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2.
    Changrob, S. et al. (2025) J. Exp. Med. 222: e20251146. | Read article

  • Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity.
    Falahat, R. et al. (2025) Proc. Natl. Acad. Sci. U. S. A. 122: e2409560122. | Read article

  • Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis.
    Yasumizu, Y. et al. (2024) NAR Cancer 6: zcae022.| Read article

  • A hybrid demultiplexing strategy that improves performance and robustness of cell hashing.
    Li, L. et al. (2024) Brief. Bioinform. 25: bbae254. | Read article

  • SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow.
    Schulz, A. R. et al. (2023) EBioMedicine 95: 104735. | Read article

NK cells

  • Selective agonists of KIR and NKG2A to evade missing self response of natural killer cells.
    Hiura, S. et al. (2025) Sci. Rep. 15: 33550. | Read article

  • GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout.
    Jünemann, W. et al. (2025) Cancer Immunol. Immunother. 74: 191. | Read article

  • A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapy.
    Weis, A. M. et al. (2025) Cell Rep. 44: 116172. | Read article

  • RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma.
    Saleh, H. A. et al. (2024) Cancer Gene Ther. 31: 1323–1334. | Read article

Myeloid cells

  • Skin-resident Langerhans cells drive neuropathic pain via chemokine-dependent neuron-immune communication.
    Pacifico, P. et al. (2026) J. Clin. Invest. 136: e192328. | Read article

  • Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.
    Mackin, S. R. et al. (2026) mBio 17: e0055726. | Read article

  • Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells.
    Schroth, S. L. et al. (2025) J. Clin. Invest. 135: e178960 | Read article

  • Thermally controlled state switches for engineered macrophages.
    Liu, A. et al. (2025) ACS Synth Biol. 14: 4304–4313. | Read article

  • Neutrophil adhesion to vessel walls impairs pulmonary circulation in COVID-19 pathology.
    Ueki, H. et al. (2025) Nat. Commun. 16: 455. | Read article

  • C-C motif chemokine receptor 2 and 7 synergistically control inflammatory monocyte recruitment but the infecting virus dictates monocyte function in the brain.
    Winkler, C. W. et al. (2024) Commun. Biol. 7: 494. | Read article

  • A two-step activation mechanism enables mast cells to differentiate their response between extracellular and invasive enterobacterial infection.
    von Beek, C. et al. (2024) Nat. Commun. 15: 904. | Read article

  • Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy.
    Acero-Bedoya, S. et al. (2024) J. Immunother. Cancer 12: e009588. | Read article

  • Human cytomegalovirus exploits STING signaling and counteracts IFN/ISG induction to facilitate infection of dendritic cells.
    Costa, B. et al. (2024) Nat. Commun. 15: 1745. | Read article

  • Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.
    Salembier, R. et al. (2024) Breast Cancer Res. 26: 63. | Read article

  • Protocol for autofluorescence-driven isolation of human peripheral blood eosinophils.
    Weihrauch, T. et al. (2024) STAR Protoc. 5: 103451. | Read article

Microglia

  • The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia.
    Albertini, G. et al. (2025) Nat. Neurosci. 29: 100–110. | Read article

  • The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively regulate TREM2 and microglia states.
    Rosner, D. et al. (2025) Neuron.114: 836–849.e11. | Read article

  • C9orf72 hexanucleotide repeat expansions impair microglial response in ALS.
    Masrori, P. et al. (2025) Nat. Neurosci. 28: 2217–2230. | Read article

  • Deep proteomic analysis of microglia reveals fundamental biological differences between model systems.
    Lloyd, A. F. et al. (2024) Cell Rep. 43: 114908. | Read article

  • APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia.
    Preman, P. et al. (2024) EMBO Mol. Med. 16: 3113–3141. | Read article

  • Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-β pathology.
    Mancuso, R. et al. (2024) Nat. Neurosci. 27: 886–900. | Read article

  • microRNA-132 regulates gene expression programs involved in microglial homeostasis.
    Walgrave, H. et al. (2023) iScience 26: 106829. | Read article

Stem cells

Progenitor cells

  • Targeted regeneration of post-radiation epithelium without promoting cancer recurrence.
    Gan, Q. et al. (2026) Res Sq. 19: rs.3.rs–7320272. | Read article

  • Whole genome methylation profiling of menstrual stem cells identifies novel biomarkers for endometriosis.
    Tiniakou, I. et al. (2026) Commun. Med. (Lond). Online ahead of print. | Read article

  • Sulfated polysaccharide prevents senescent adipocyte-driven osteonecrosis by stem cell fate reprogramming.
    Zhang, S. et al. (2026) Bioact. Mater. 60: 163–190. | Read article

  • Enhanced renal ischemia/reperfusion injury repair potential of exosomes derived from B7-H1high mesenchymal stem cells.
    He, J. et al. (2025) Front. Genet. 16: 1516626. | Read article

  • Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
    Molteni, R. et al. (2025) Nat. Med. 31: 1911–1924. | Read article

  • Enrichment strategies to enhance genome editing.
    Mikkelsen, N. et al. (2023) J. Biomed. Sci. 30: 51. | Read article

  • Myeloid fatty acid metabolism activates neighboring hematopoietic stem cells to promote heart failure with preserved ejection fraction.
    Filipp, M. et al. (2025) Circulation 151: 1451–1466. | Read article

  • Cell-surface LAMP1 is a senescence marker in aging and idiopathic pulmonary fibrosis.
    Meca-Laguna, G. et al. (2025) Aging Cell 24: e70141. | Read article

iPSC-derived cells

  • Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease. x
    Sawamoto, N. et al. (2025) Nature 641: 971–977. | Read article

  • CD133/CD49a discriminate between human pluripotent stem cell-derived pancreatic beta and alpha cells.
    Tian, C. et al. (2026) Stem Cell Reports 21: 102828 | Read article

  • Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology.
    Wickenhagen, A. et al. (2025) Nat. Commun. 16: 594. | Read article

  • Cell-context response to germ layer differentiation signals is predetermined by the epigenome in regionalized epiblast populations.
    Menezes, N. A. et al. (2025) Nat. Commun. 16: 5000. | Read article

  • Cytokine signaling converging on IL11 in ILD fibroblasts provokes aberrant epithelial differentiation signatures.
    Kastlmeier, M. T. et al. (2023) Front. Immunol. 14: 1128239. | Read article

  • Increased prime edit rates in KCNQ2 and SCN1A via single nicking all-in-one plasmids.
    Dirkx, N. et al. (2023) BMC Biol. 21: 156. | Read article

Myoblasts and muscle stem cells

  • Mechanisms of chimeric cell therapy in Duchenne Muscular Dystrophy.
    Siemionow, M. et al. (2024) Biomedicines 12: 1996. | Read article

  • Developing advanced chimeric cell therapy for Duchenne Muscular Dystrophy.
    Budzynska, K. et al. (2024) Int. J. Mol. Sci. 25: 10947. | Read article

  • Optimisation of cell fate determination for cultivated muscle differentiation.
    Melzener, L. et al. (2024) Commun. Biol. 7: 1493. | Read article

  • Safety and efficacy of DT-DEC01 therapy in Duchenne Muscular Dystrophy patients: A 12-month follow-up study after systemic intraosseous administration.
    Siemionow, M. et al. (2023) Stem Cell Rev. Rep. 19: 2724–2740. | Read article

  • Dystrophin expressing chimeric (DEC) cell therapy for Duchenne Muscular Dystrophy: A first-in-human study with minimum 6 months follow-up.
    Heydemann, A. et al. (2023) Stem Cell Rev. Rep. 19: 1340–1359. | Read article

  • Assessment of motor unit potentials duration as the biomarker of DT-DEC01 cell therapy efficacy in Duchenne Muscular Dystrophy patients up to 12 months after systemic-intraosseous administration.
    Niezgoda, A. et al. (2023) Arch. Immunol. Ther. Exp. (Warsz) 71: 24. | Read article

GMP-compliant cell sorting

Regulatory T cells

  • Regulatory T cell therapies: biological foundations, engineering strategies, and clinical translation.
    Plaisse, C. et al. (2026) Front. Immunol. 17: 1797186. | Read article

  • Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation.
    Zarrinrad, G. et al. (2026) Mol. Ther. Adv. 34: 201735. | Read article

  • Regulatory T cell-based adoptive cell therapy in autoimmunity.
    Gozálvez, E. et al. (2025) Int. J. Mol. Sci. 26:1 0340. | Read article

  • Unlocking the therapeutic potential of thymus-isolated regulatory T cells.
    Hu, Y. et al. (2025) Front. Immunol. 16: 1612360. | Read article

  • Therapeutic potential of regulatory T cells for stem cell regulation: Insights from Treg-mediated enhancement of limbal stem cell functions.
    Fang, F. et al. (2025) iScience 28: 112515. | Read article

  • Feasibility and safety of personalized, multi-target, adoptive cell therapy (IMA101): First-in-human clinical trial in patients with advanced metastatic cancer.
    Tsimberidou, A. M. et al. (2023) Cancer Immunol. Res. 11: 925–945. | Read article

  • Clinical manufacturing of regulatory T cell products for adoptive cell therapy and strategies to improve therapeutic efficacy.
    Baron, K. J. et al. (2023) Organogenesis. 19: 2164159. | Read article

  • Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective.
    Amini, L. et al. (2023) Front. Cell Dev. Biol. 10: 1081644. | Read article

  • Barriers to Treg therapy in Europe: From production to regulation.
    Hennessy, C. et al. (2023) Front. Med. (Lausanne) 10: 1090721. | Read article

  • A novel GMP protocol to produce high-quality Treg cells from the pediatric thymic tissue to be employed as cellular therapy.
    Bernaldo-De-Quirós, E. et al. (2022) Front. Immunol. 13: 893576. | Read article

  • The emerging role of regulatory cell-based therapy in autoimmune disease.
    Ghobadinezhad, F. et al. (2022) Front. Immunol. 13: 1075813. | Read article

CAR T cells

  • B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer.
    Stucchi, S. et al. (2025) J. Immunother. Cancer 13: e011533. | Read article

  • CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.
    Teppert, K. et al. (2024) Mol. Ther. Oncol. 32: 200797. | Read article

  • Targeting TAG-72 in cutaneous T cell lymphoma.
    Evtimov, V. J. et al. (2024) Heliyon 10: e36298. | Read article

  • Preclinical evaluation of novel folate receptor 1-directed CAR T cells for ovarian cancer.
    Daigre, J. et al. (2024) Cancers (Basel) 16: 333. | Read article

  • High specificity of engineered T cells with third generation CAR (CD28-4-1BB-CD3-ζ) based on biotin-bound monomeric streptavidin for potential tumor immunotherapy.
    Gallego-Valle, J. et al. (2024) Front. Immunol. 15: 1448752. | Read article

  • CAR-T cell manufacturing landscape-lessons from the past decade and considerations for early clinical development.
    Dias, J. et al. (2024) Mol. Ther. Methods Clin. Dev. 32: 101250. | Read article

  • Identification and characterization of fully human FOLR1-targeting CAR T cells for the treatment of ovarian cancer.
    Bethke, M. et al. (2024) Cells 13: 1880. | Read article

  • Fully closed cell sorter for immune cell therapy manufacturing.
    Matsumoto, M. et al. (2023) Mol. Ther. Methods Clin. Dev. 30: 367–376. | Read article

  • Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.
    Kalaitsidou, M. et al. (2023) Front. Immunol. 14: 1256491. | Read article

  • Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.
    Song, H. W. et al. (2022) Int. Rev. Immunol. 41: 638–648. | Read article

  • Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids.
    Suraiya, A. B. et al. (2022) Transl. Oncol. 24: 101477. | Read article

Other applications

Nuclei and single-cell omics

  • Nuclei isolation methods on frozen clotted blood samples.
    Cuevas, M. et al. (2026) Bio Protoc. 16: e5573. | Read article

  • The age-dependent resident myonuclear multiomic response to an acute skeletal muscle hypertrophic stimulus in mice.
    Koopmans, P. J. et al. (2026) Adv. Sci. (Weinh) 13: e21633. | Read article

  • Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson's disease.
    Gaertner, Z. et al. (2025) Elife 13: RP101035. | Read article

  • Complementation testing identifies genes mediating effects at quantitative trait loci underlying fear-related behavior.
    Chen, P. B. et al. (2024) Cell Genom. 4: 100545. | Read article

  • Multiomics characterization of a less invasive microfluidic-based cell sorting technique.
    Choudhury, F. K. et al. (2024) J. Proteome Res. 23: 3096–3107. | Read article

  • Single-cell methylation analysis of brain tissue prioritizes mutations that alter transcription.
    Flint, J. et al. (2023) Cell Genom. 3: 100454. | Read article

  • Protocol for the isolation of CD8+ tumor-infiltrating lymphocytes from human tumors and their characterization by single-cell immune profiling and multiome.
    Anadon, C. M. et al. (2022) STAR Protoc.3: 101649. | Read article

  • Practical considerations for single-cell genomics.
    Regan, C. et al. (2022) Curr. Protoc. 2: e498. | Read article

  • Minimizing the ex vivo confounds of cell-isolation techniques on transcriptomic and translatomic profiles of purified microglia.
    Ocañas, S. R. et al. (2022) eNeuro 9: ENEURO.0348–21.2022. | Read article

  • Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
    Zazhytska, M. et al. (2022) Cell 185: 1052–1064. | Read article

Cell lines

  • Comparison of functional characterization of cancer stem cells in different tumor tissues of pseudomyxoma peritonei.
    Zhou, H. et al. (2024) J. Transl. Med. 22: 1022. | Read article

  • The secoiridoid glycoside Gentiopicroside is a USP22 inhibitor with potent antitumor immunotherapeutic activity.
    Lu, W. et al. (2024) Biomed Pharmacother. 177: 116974 | Read article

  • Development and testing of a versatile genome editing application reporter (V-GEAR) system.
    Kleinboehl, E. W. et al. (2024) Mol. Ther. Methods Clin. Dev. 32: 101253 | Read article

  • The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses.
    Palakurty, S. et al. (2024) Cell Rep. 43: 114809. | Read article

  • Development of a monoclonal antibody to study MARCH6, an E3 ligase that regulates proteins that control lipid homeostasis.
    Xu, S. et al. (2024) J. Lipid Res. 65: 100650. | Read article

  • Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus.
    Adams, L. J. et al. (2024) Cell 187: 360–374.e19. | Read article

  • Genomically mined acoustic reporter genes for real-time in vivo monitoring of tumors and tumor-homing bacteria.
    Hurt, R. C. et al. (2023) Nat. Biotechnol. 41: 919–931. | Read article

Biosafety

  • Generation of endotoxin-specific monoclonal antibodies by phage and yeast display for capturing endotoxin.
    Fux, A. C. et al. (2024) Int. J. Mol. Sci. 25: 2297. | Read article

  • Chlamydia trachomatis alters mitochondrial protein composition and secretes effector proteins that target mitochondria.
    Dimond, Z. et al. (2022) MSphere 7: e0042322. | Read article

  • Specific isolation of Clostridium botulinum group I cells by phage lysin cell wall binding domain with the aid of S-layer disruption.
    Zhang, Z. et al. (2022) Int. J. Mol. Sci. 23: 8391. | Read article

You have previously chosen International as your location.
What do you want to do?